Skip to main navigation
Skip to search
Skip to main content
University of Southern Denmark Home
Help & FAQ
Dansk
English
Home
Researchers
Research Units
Research output
Activities
Projects
Press / Media
Prizes
Teaching
Impacts
Datasets
Search by expertise, name or affiliation
Research collaboration with Novartis - 243,000
Søe, Kent (Recipient)
IRS - Lillebælt Hospital (Kolding)
Prize
:
Prizes, scholarships, distinctions
Description
Obtained 243,000 kr from Novartis Denmark to cover expenses of my investigator initiated phase II clinical trial entitled: “Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer”
Awarded date
2008
Degree of recognition
Local
Fingerprint
Zoledronic Acid
100%
Phase II Clinical Trials
93%
Denmark
81%
Multiple Myeloma
75%
Research Personnel
53%
Breast Neoplasms
48%